Rayitek Projects Significant Losses for 2024: Estimated Deficit of ¥53 Million to ¥68 Million
On January 17, Rayitek released its performance forecast for 2024, indicating that the net profit attributable to shareholders is expected to incur a loss ranging from ¥53 million to ¥68 million. This figure represents an increase in losses by ¥33.397 million to ¥48.397 million compared to the previous year, marking a year-on-year increase of 170.37% to 246.89%.
The announcement highlighted the main factors contributing to this downturn:
Increased Market Competition: The company faces intensified competition within the industry and adjustments in market demand. Additionally, the Jiaxing project is still in the ramp-up phase, leading to relatively high fixed costs and a decline in the overall gross profit margin.
Rising Management and Financial Costs: The commencement of the Jiaxing project has resulted in increased depreciation and capitalized interest, with management expenses and financial costs rising approximately 30% and 115% respectively. This comprehensive impact has exacerbated the losses compared to the previous year.
Despite these challenges, the company remains proactive in adapting to the changing economic environment. Rayitek is focusing on market expansion, adjusting its product structure, and steadily enhancing the production capacity and yield of the Jiaxing production line. It anticipates achieving operating revenues between ¥330 million and ¥350 million, representing a year-on-year growth of 19.60% to 26.84%.
2026-09-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
-
U.S. Includes Lithium in National Defense Stockpile for First Time, Plans to Purchase 16,200 Tons Over Five Years
-
COIM Group Expands Alkyd and Acrylic Resin Production Capacity in the Netherlands
-
Canada’s Acynonapyr Review Offers More Than a New Mite Product
-
West Asia’s Conflict Is Testing the Hidden Fragility of Pharma Trade
-
India’s Latest Manufacturing Clarification Is Really a Delayed Regulatory Line in the Sand
-
Global Ag M&A in 2025 Looked Less Like Expansion and More Like Selection
-
South Korea Tests Arctic Commercial Route as Asian Exporters Seek New Logistics Alternatives
-
Affordable GLP-1s Could Rewrite the Global Obesity Market
-
South Africa Wants Lenacapavir at Home, Not Just Imported
Recommend Reading
-
European Petrochemicals Enter 'Era of Downsizing' as Dow, TotalEnergies, Shell Exit Older Cracker Assets
-
Laboratoire PYC showcases its collagen-driven nutricosmetic innovations
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
Wanhua's BorsodChem Restarts 650,000 T/Y of MDI and TDI Capacity in Europe
-
Major Fire Hits China-Russia Joint 2.7 Million T/Y Polyolefins Project, Killing 6 Chinese Nationals and Injuring 152 People
-
This week, the domestic anhydrous hydrogen fluoride market operated steadily (2.9-2.13)
-
Viprostol Usage & Precautions: What You Need to Know
-
What is the Formula for Ammonia? (NH3 Structure & Properties)
-
MTBE Market Trend Shows Strong Fluctuations in China
-
Ethyl Acetate Market Trends Remain Stable